Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic SCT with Fludarabine Conditioning in High-Risk CLL
NCT00281983Phase 2Completed
- Sponsor
- German CLL Study Group
- Start
- Jun 2000
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide in chronic lymphocytic leukemia (CLL), Waldenström's macroglobulinemia (WM), sponsored by German CLL Study Group. Started Jun 2000; status: completed.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
chronic lymphocytic leukemia (CLL)Waldenström's macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00281983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281983.